QUALIA OTO, INC.

DALLAS, TX · Founded 2017 · Medtech · Private

Implantable cochlear implant with novel thin-film circuit design enabling higher-resolution hearing through increased electrode data bandwidth

Claim this profile

Follows are private to you and power your alerts

Updated · qualiaoto.com

Sector
Medtech
Headquarters
DALLAS, TX
Founded
2017
Latest Form D
$1.4M, Jan 2022
Total capital
$3.2M
Federal grants
$1.8M
4 awards · 2022–2026
Rank in peer group#36 of 477
Private capital raised
$1.4M
1 Form D · last Jan 2022
57 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20222023202420252026FEDERAL ↑EQUITY ↓Cumulative $3.2M$234K$277K$305K$981K1st Form D$1.4M
20222023202420252026FEDERAL ↑EQUITY ↓Cumulative $3.2M$234K$277K$305K$981K1st Form D$1.4M

Latest events

  • Federal grantHealth and Human S · Phase II · Shape-Adaptive Cochlear Implant Electrode Arrays$981K
  • Federal grantHealth and Human S · Phase I · Robotic-Inserted, Shape-Conforming Cochlear Implant Electrode Arrays$305K
  • Federal grantHealth and Human S · Phase I · Shape-Adaptive Cochlear Implant Electrode Arrays$277K
  • Federal grantNSF · Phase I · STTR Phase I:Matrix-Addressed, Thin-Film Cochlear Implant Electrode Arrays$234K
  • Private capital raisedForm D · SEC · 1st filing$1.4M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#36 · top 8%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Benedict VoitExecutive OfficerNamed in SEC Form D filings
  • Connie ManzExecutive Officer, DirectorNamed in SEC Form D filings
  • Walter VoitExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • SONOVOICE, INC.Similar federal contract value in Medtech · null in contracts
  • ADEPTRIX CORPSimilar federal contract value in Medtech · null in contracts
  • OtoNexus Medical Technologies, Inc.Similar federal contract value in Medtech · null in contracts
  • BIOSYNTAGMA, LLCSimilar federal contract value in Medtech · null in contracts
  • ViaLase, Inc.Similar federal contract value in Medtech · null in contracts
  • R3 Vascular Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .